Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to November 2026.

37,497

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,881

Class I recallsReasonable probability of serious health consequences

24,543

Class II recallsTemporary or medically reversible health consequences

2,935

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,098 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/family-farmstead-dairy-announces-recall-all-cheddar-cheese-products-because-possible-health-riskPublished November 10, 2026

Most affected stateHawaii 200 recalls mention this state

State: MD ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated November 10, 2026 ET

Summary (Year to date)

1,956 recalls have been announced year to date.
Oct 2026 was 4% higher than the previous complete period (Sep 2026: 209).
The highest complete period was Jun 2026 (300).
Nov 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,543
Class I	9,881
Class III	2,935
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,543
Class I	9,881
Class III	2,935
Not Yet Classified	2

FDA Recall United States TerminatedTerminated: March 31, 2017Historical recordClass III

Infiniti Creations, LLC

Product: HCG Plus. 2oz HCG Drops. Blue Glass
Reason: The firm announced a voluntary recall of various dietary supplement products due to misbranding and some products may contain undeclared HCG.
Published: November 30, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: November 8, 2018Historical recordClass III

Zeasorb AF (miconazole nitrate), 2%, cures most athlete's foot, Net wt. 2.5 OZ (71 g), Manufactured for: Steifel Laboratories, Inc., Research Triangle Park, NC 27709, UPC 0 73462 15065 1; NDC 0145-1506-01

by GSK Consumer Healthcare

Reason: Labeling Not Elsewhere Classified: front labels have the incorrect NDC or 0145-1506-01 instead of the correct NDC of 0145-1506-05 and some back labels have the incorrect indication stating "use for the cure of most jock itch" rather than "use for the cure of most athlete's foot".
Published: November 23, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 17, 2017Historical recordClass II

L-Cysteine Hydrochloride Injection, USP, 50 mg/mL, 50 mL Pharmacy Bulk Package Vials (NDC 66758-005-01), packaged in 5 x 50 mL Vials per carton(NDC 66758-005-02), Rx only, Manufactured for: Sandoz, Inc., Princeton, NJ.

by Sandoz Inc

Reason: Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that the product sterility may be compromised.
Published: November 23, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 17, 2017Historical recordClass II

L-Cysteine Hydrochloride Injection, USP, 0.5 g/10 mL (50 mg/mL), 10 mL Single Dose Vial (NDC 66758-004-01), packaged in 10 x 10mL Vials per carton (NDC 66758-004-02), Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540.

by Sandoz Inc

Reason: Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that the product sterility may be compromised.
Published: November 23, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 12, 2017Historical recordClass III

FIRST Omeprazole 2mg/mL in FIRST PPI Suspension Compounding Kit , 3 OZ, Rx only, Manufactured for CutisPharma Wilmington, MA, NDC# 65628-070-03

by CutisPharma, Inc.

Reason: Labeling: Label error on declared strength. Package Insert -Error in the Description section of the package insert refers to the strength as 3mg per mL; however it should state 2mg per mL
Published: November 23, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: September 12, 2017Historical recordClass III

FIRST Omeprazole 2mg/mL in FIRST PPI Suspension Compounding Kit , 5 oz., Rx only, Manufactured for CutisPharma Wilmington, MA, NDC# 65628-070-05

by CutisPharma, Inc.

Reason: Labeling: Label error on declared strength. Package Insert -Error in the Description section of the package insert refers to the strength as 3mg per mL; however it should state 2mg per mL
Published: November 23, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 29, 2017Historical recordClass III

Bupropion Hydrochloride Extended-Release Tablets, USP (XL), 300 mg, a) 90-count bottle (NDC 68001-264-05), b) 500-count bottle (NDC 68001-264-03) , Rx only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India For BluePoint Laboratories

by Amerisource Health Services

Reason: Failed Dissolution Specifications: The firm was notified that there was a dissolution out of specification result on the 6 month stability samples.
Published: November 23, 2016
Distribution: Nationwide

View recall →

FDA Recall United States TerminatedTerminated: April 25, 2017Historical recordClass I

McCain Foods USA

Product: Frozen Onion Rings sold and distributed under the following…
Reason: Product label does not declare milk.
Published: November 23, 2016
Distribution: Recalled product was distributed to dire…

View recall →

FDA Recall TerminatedTerminated: August 28, 2018Historical recordClass III

Clonazepam Tablets, USP, 1.0 mg, packaged in a 100- count unit dose box of 10 x 10 blister cards, Rx only, Manufactured by Mylan Pharmaceuticals Inc, Morgantown, WV, 26505, NDC 51079-882-20

by Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Reason: Failed Impurities/Degradation Specifications: out of specification result for Clonazepam Related Compound (RC) A (a known impurity) at 16 month timepoint.
Published: November 16, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: August 28, 2018Historical recordClass III

Clonazepam Tablets, USP, 0.5 mg, packaged in a)100- count unit dose box of 10 x 10 blister cards (NDC 51079-881-20) and b) 300-count unit dose box of 10 x 30 punch cards (NDC 51079-881-56), Rx only, Manufactured by Mylan Pharmaceuticals Inc, Morgantown, WV, 26505

by Mylan Institutional, Inc. (d.b.a. UDL Laboratories)

Reason: Failed Impurities/Degradation Specifications: out of specification result for Clonazepam Related Compound (RC) A (a known impurity) at 15 month timepoint.
Published: November 16, 2016
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: June 6, 2018Historical recordClass III